HRMY PEER ANALYSIS

Harmony Biosciences Holdings — metric-by-metric comparison with peers and the industry median

HRMYHarmony Biosciences Holdings

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

HRMYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	HRMY	TLX	MSB	CSL	Ind. Median
P/E	14.94●	—	—	30.02	17.81
P/B	2.39	6.56	—	2.24●	3.49
EV/EBITDA	7.46●	123.31	—	10.37	14.92
P/S	2.42●	3.34	31.91	2.67	10.89

Financial Health
Metric	HRMY	TLX	MSB	CSL	Ind. Median
Current Ratio	3.58●	1.43	—	2.57	5.90
Debt/Equity	22.7%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	-1.86●	13.13	—	2.22	1.15

Profitability
Metric	HRMY	TLX	MSB	CSL	Ind. Median
Net Margin	16.2%●	-0.9%	-115.3%	9.2%	-125.7%
ROE	17.9%●	-1.8%	-11.3%	7.7%	-47.5%
ROA	12.5%●	-0.7%	-8.6%	3.8%	-35.8%
EBITDA Margin	26.0%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	HRMY	TLX	MSB	CSL	Ind. Median
Rev. Growth	20.7%	56.3%	410.4%●	4.8%	5.1%
NI Growth	-4.7%●	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	HRMY	AGIO	OCUL	NUVB	AUPH	ADMA	Ind. Median
P/E	14.94	—	—	—	7.15●	13.29	17.81
P/B	2.39	1.98●	3.72	6.62	3.76	5.63	3.49
EV/EBITDA	7.46●	—	—	—	11.26	10.22	14.92
P/S	2.42●	33.28	41.60	14.78	7.15	4.31	10.89

Financial Health
Metric	HRMY	AGIO	OCUL	NUVB	AUPH	ADMA	Ind. Median
Current Ratio	3.58	14.19	14.81●	7.44	5.55	6.95	5.90
Debt/Equity	22.7%	3.2%	13.7%	3.1%●	12.1%	52.4%	10.9%
NetDebt/EBITDA	-1.86	1.68	2.14	4.04	-1.92●	0.30	1.15

Profitability
Metric	HRMY	AGIO	OCUL	NUVB	AUPH	ADMA	Ind. Median
Net Margin	16.2%	-639.8%	-558.2%	-102.1%	100.0%●	32.4%	-125.7%
ROE	17.9%	-32.8%	-68.6%	-39.5%	65.0%●	43.3%	-47.5%
ROA	12.5%	-30.8%	-51.0%	-26.5%	48.5%●	28.1%	-35.8%
EBITDA Margin	26.0%	-633.4%	-527.0%	-90.7%	54.2%●	43.4%	-105.8%

Growth + Dividend
Metric	HRMY	AGIO	OCUL	NUVB	AUPH	ADMA	Ind. Median
Rev. Growth	20.7%	78.3%	-12.8%	1,205.5%●	20.6%	11.0%	5.1%
NI Growth	-4.7%	—	—	—	648.4%●	-20.0%	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on HRMY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.